GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

9 Jan 2020 07:00

RNS Number : 1997Z
InnovaDerma PLC
09 January 2020
 

LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Company")

Trading Statement

InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life sciences products, provides a trading update for the six months ended 31 December 2019.

The Company generated revenues of £5.0m, up c.28% compared to the same period last year (H1 2019: £3.9m). The increase in revenue was driven predominantly by Skinny Tan and its performance on the Company's DTC platform and in the UK retail channel. The former has continued to benefit from a revised digital engagement strategy and investment in all three key geographical markets: UK, US and Australia. Product innovation remains key to the business and the first six months included the launch of the limited-edition Choc range in Superdrug, which resulted in exceptional demand and the continued success of Wonder Serum in Boots has provided a strong platform for the season ahead. These initiatives have alleviated the effects of a softer UK high street retail environment and shelf space rationalisation, typical of seasonal products such as Skinny Tan.

The UK DTC channel accounted for 56% of total revenue (H1 2019: 59%). Skinny Tan DTC revenue was supported by Black Friday and Christmas promotions, up c.27% compared to the same period last year. UK retail revenue was almost double that of H1 2019, driven by the Skinny Tan rollout into Boots' stores, an opening order from Tesco, and continued support from Superdrug. Pleasingly, our core brand also made excellent progress in Australia and the US DTC markets, with the introduction of new products. Whilst these two territories remain a small proportion of our overall revenue, growth was robust.

Roots revenues were lower than expected due to competitive shelf positioning, however, new products, particularly Platinum Colour Protect, performed well. Charles + Lee continued to build momentum with Australian retailers and almost doubled revenues compared to last year.

Life Sciences' revenue increased by 71% on the previous year as a result of DTC sales driven by online 'influencers', predominantly in the US.

As in previous years, the Company expects revenue and profit growth to be strongly weighted to H2 FY2020, reflecting the peak tanning season. Skinny Tan remains well positioned to perform well in the UK despite a challenging outlook for the UK retail market. Charles & Lee is growing in popularity, and we look forward to expanding its geographical spread. Roots will receive extra marketing and product development focus to expand its customer base and product offering in 2020.

The momentum of the first half coupled with our forthcoming new category launch give us much confidence for the full year. The balance sheet remains healthy and with an increased retail footprint coupled with continued focus on our DTC channels in core regions, the Company expects to generate strong revenue and profit growth in the second half of the year.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

InnovaDerma

Joe Bayer

Kieran Callan c/o TB Cardew

www.innovaderma.com

 

 

+61 (0)3 9863 8030

+44 (0)20 7930 0777

finnCap Ltd

Geoff Nash/ Kate Bannatyne

Alice Lane/Manasa Patil - Corporate Broking

 

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

innovaDerma@tbcardew.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKFBNPBKDCDK
Date   Source Headline
8th Mar 201810:13 amRNSTrading Statement
15th Feb 20187:00 amRNSHalf-year Report
2nd Feb 20187:00 amRNSDirector/PDMR Shareholding
16th Jan 20187:00 amRNSTrading Statement
15th Dec 20177:00 amRNSIssue of Warrants and Issue of Equity
24th Nov 201711:37 amRNSHolding(s) in Company
10th Nov 20177:00 amRNSAllotment of Shares
8th Nov 201710:47 amRNSResult of AGM
8th Nov 20177:00 amRNSAGM Statement and Operational Update
7th Nov 20178:16 amRNSHolding(s) in Company
20th Oct 20177:53 amRNSAllotment of Shares
18th Oct 20179:52 amRNSASA Ruling
16th Oct 20177:00 amRNSHolding(s) in Company
16th Oct 20177:00 amRNSAdmission of Shares
12th Oct 20175:18 pmRNSNotice of AGM & Posting of Annual Report
12th Oct 201710:40 amRNSHolding(s) in Company
9th Oct 20177:00 amRNSTotal Voting Rights
6th Oct 20179:55 amRNSCompletion of Placing
6th Oct 20177:00 amRNSProposed Placing
2nd Oct 20177:00 amRNSAllotment of Shares
27th Sep 20177:00 amRNSOperational Update
14th Sep 20177:00 amRNSTransfer of Shares
12th Sep 20177:00 amRNSFinal Results
4th Sep 20177:00 amRNSOperational Update
11th Aug 20179:30 amRNSNotice of Results
28th Jul 201711:58 amRNSDirector/PDMR Shareholding
26th Jul 20172:22 pmRNSAllotment of Shares
26th Jul 20177:00 amRNSOperational Update
26th Jul 20177:00 amRNSDirectorate Change and Change Of Adviser
19th Jun 20174:40 pmRNSSecond Price Monitoring Extn
19th Jun 20174:35 pmRNSPrice Monitoring Extension
19th Jun 20172:05 pmRNSSecond Price Monitoring Extn
19th Jun 20172:00 pmRNSPrice Monitoring Extension
19th Jun 201711:05 amRNSSecond Price Monitoring Extn
19th Jun 201711:00 amRNSPrice Monitoring Extension
19th Jun 20179:05 amRNSSecond Price Monitoring Extn
19th Jun 20179:00 amRNSPrice Monitoring Extension
19th Jun 20178:18 amRNSTrading Statement (Replacement)
19th Jun 20177:00 amRNSTrading Statement
8th Jun 20177:00 amRNSExercise of Broker Warrants
1st Jun 20177:00 amRNSInnovaDerma secures Boots Ireland
22nd May 20172:05 pmRNSSecond Price Monitoring Extn
22nd May 20172:00 pmRNSPrice Monitoring Extension
22nd May 20177:00 amRNSLaunch of haircare range and entry into skincare
15th May 20179:47 amRNSHolding(s) in Company
10th May 20172:25 pmRNSHolding(s) in Company
10th May 20172:21 pmRNSHolding(s) in Company
8th May 20173:54 pmRNSAllotment of Shares
5th May 20174:40 pmRNSSecond Price Monitoring Extn
5th May 20174:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.